Darren Davis, PhD
[email protected]
EDUCATION
PhD, molecular biology February 2000
University of Queensland, Brisbane, Queensland, Australia
CAREER HIGHLIGHTS
Academic
§ Prestigious NHMRC Peter Doherty Postdoctoral Fellowship
§ 17 peer-reviewed research publications
§ 18 conference papers, including 2 at the prestigious American Heart Association
§ AU $400,000 in successful research grants
§ 4,000,000 words edited for research papers prior to publication
Industry
§ Founded a direct-to-consumer genetic testing service in Nairobi, Kenya
§ Technical lead on project that protected a $300 million annual revenue source
§ US $2.5 million cost savings from new assay development
§ Changed paradigm of Illumina reagent QC with enzyme activity assay development
§ Expert microarray data analysis for >200 process/product improvement projects
SKILLS
Lab Experience
§ Expertise in a broad range of molecular assays, including developing, qualifying, and validating new assays and optimizing or troubleshooting existing assays
§ Assay expertise: RT-PCR, RNase protection assay, PCR, real-time PCR, sequencing, genotyping, ELISA, immunoblot, immunofluorescence, zymography, chromogenic substrate assay, enzyme activity assays, FRET & molecular beacon fluorescence assays, binding assays, cell culture
§ 13 years of academic research experience and 7 years of biotech industry experience
Communication & Data Analysis
§ Excellent written & verbal communication skills
– 17 scientific publications, > 50 biotech project presentations
§ Proficient in writing assay protocols, validation protocols and reports, and engineering reports
§ Expertise at editing scientific journal articles for content and language
– 4,000,000 words edited from 1,500 papers
Management Experience
Executive
§ Founded a direct-to-consumer genetic testing service
Biotech Industry Project Management
§ Managed multiple parallel data analysis and assay development projects
§ Supervised other scientists
§ Technical lead on major new product/process improvement projects
§ Managed the enzyme assay development program
Academic Research Project Management
§ Designed experimental strategies and applied for funding
§ Responsible for all aspects of postdoctoral project completion
§ Supervised students and junior staff members
EMPLOYMENT
HISTORY
Freelance Scientific Editor: AsiaEdit (Remote), June 2020–present; Cactus Communications (Remote), May 2017–present
Scientist I/II: Illumina, Inc, San Diego, CA, March 2009–June 2016
Consulting Scientist II: Ingenuity Systems, Redwood City, CA, July 2001–March 2009
NHMRC Postdoctoral Fellow: University of NSW, Sydney, Australia, Jan 2003–Jan 2007
Hospital Scientist: Prince of Wales Hospital, Sydney, Australia, May 2000–December 2002
Research Assistant/PhD: University of Queensland, Australia, January 1994–February 2000
PUBLICATIONS
Invited Reviews
Davis DR, Erlich JH. Cardiac tissue factor: physiology and fibrosis. Clinical and Experimental Physiology and Pharmacology 2008;35:342-348.
Refereed Journal Articles
1. Davis D, Wilson K, Sam M, Kennedy S, Mackman N, Charlesworth J, Erlich J. Journal of Molecular and Cellular Cardiology 2007;42(3):559-571.
2. Sevastos J, Kennedy S, Sam M, Sevastos J, Kennedy S, Sam M, Davis D, Peake P, Charlesworth J, Erlich J. Blood 2007;109(2):577-583.
3. Davis D, Liyou N, Lockwood D, Johnson A. Clinical Genetics 2002;61(5):363-368.
4. Davis D, Liyou N, Johnson A. Journal of Human Hypertension 2001;15:653-654.
5. Johnson AG, Nguyen TV, Davis DR. Journal of Hypertension 2001;19:1053-1060.
6. Alam S, Liyou N, Davis D, Tresillian M, Johnson AG. Journal of Human Hypertension 2000;14(3):199-203.
7. Liyou N, Davis D, James K, Simons L, Friedlander Y, Simons J, McCallum J, Johnson A. Clinical and Experimental Pharmacology and Physiology 1999;26(7):525-526.
8. Mellick GD, Buchanan DD, McCann SJ, James KM, Johnson AG, Davis DR, Liyou NE, Chan D, Le Couteur DG. Movement Disorders 1999;14(2):219-224.
9. Mellick GD, Buchanan DD, McCann SJ, James KM, Johnson AG, Davis DR, Liyou NE, Chan D, Le Couteur DG. Movement Disorders 1999;14(2):219–224.
10. Mellick GD, Buchanan DD, McCann SJ, Davis DR, Le Couteur DG, Chan D, Johnson AG. European Neurology 1999;41(2):103-106.
11. Liyou N, Simons L, Friedlander Y, Simons J, MaCallum J, O’Shaughnessy K, Davis D, Johnson A. Clinical Genetics 1999;54(6):528-529.
12. Davis DR, Liyou NE, Johnson AG. American Journal of Hypertension 1998;11(8 pt 1):1037-1038.
13. Davis DR, Johnson AG. Clinical Genetics 1996; 50(5):435-436.
14. Johnson AG, Simons LA, Friedlander Y, Simons J, Davis DR, MaCallum J. Journal of Hypertension 1996; 14(9):1061-1065.
15. Davis D, Johnson AG. American Journal of Hypertension 1996;9(5):515.
16. Johnson AG, Simons LA, Friedlander Y, Simons J, Davis DR, MaCallum J. Journal of Human Hypertension 1996; 10(3):167-169.
Conference Papers and Abstracts
1. Davis D, Wilson K, Sam M, Kennedy S, Mackman N, Erlich J. Circulation 2006;114 (18 Suppl II):II-29.
2. Sam MJ, Kennedy SE, Davis DR, Charlesworth JA, Peake PW, Erlich JH. Journal of the American Society of Nephrology 2006;17:248A.
3. Kennedy SE, Symonds KJ, Charlesworth JA, Sam M, Davis DR, Erlich JH. Journal of the American Society of Nephrology 2006;17:708A.
4. Kennedy SE, Sam M, Peake PW, Davis DR, Erlich JH. Nephrology 2006;11(s2):iiiA7.
5. Erlich JH, Kennedy SE, Sevastos J, Davis DR, Sam MJ, Charlesworth JA. Journal of the American Society of Nephrology 2005;16:625A.
6. Sam MJ, Kennedy SE, Davis DR, Peake PW, Charlesworth JA, Erlich JH. Journal of the American Society of Nephrology 2005;16:424A.
7. Kennedy S, Sevastos J, Davis D, Sam M, Charlesworth J, Erlich J. Nephrology 2005;10(Suppl):A419.
8. Sam M, Kennedy S, Davis D, Peake P, Charlesworth J, Erlich J. Nephrology 2005;10(Suppl):A379.
9. Davis D, Wilson K, Sam M, Mackman N, Erlich J. Circulation 2004;110(17 Suppl III):299.
10. Sevastos J, Davis DR, Charlesworth JA, Erlich JH.. Nephrology 2004;9(Suppl1):A3.
11. Davis DR, Kennedy SE, Sevastos J, Charlesworth JA, Erlich JH. Nephrology2004;9(Suppl 1):A31.
12. Kennedy SE, Davis DR, Sevastos J, Charlesworth JA, Peake P, Pussell BA, Erlich JH. Nephrology 2004;9(Suppl 1):A31.
13. Sevastos J, Davis DR, Charlesworth JA, Erlich JH. Journal of the American Society of Nephrology 2004;15:9A.
14. Kennedy SE, Davis DR, Sevastos J, Charlesworth JA, Peake P, Pussell BA, Erlich JH. Journal of the American Society of Nephrology 2004;15:688A.
15. Erlich JH, Sevastos J, Davis DR, Charlesworth JA. Journal of the American Society of Nephrology 2003;14:626A.
16. Sevastos J, Davis DR, Charlesworth JA, Pussell BA, Peake P, Erlich JH. Nephrology 2003;8(Suppl 3):A70.
17. Davis DR, Johnson AG. 23rd Annual Scientific Meeting of the High Blood Pressure Research Council of Australia, Melbourne, December 2001.
18. Davis D, Liyou N, Johnson A. Journal of Hypertension 2000;18(Suppl 4):S176
Only Employers can view Contact Details. Request Access